AI Generated Image
Cramer's lightning round: Buy Vistra
CNBC • • technology
Key Points:
- Jim Cramer expresses caution about investing in Fair Isaac Corporation due to concerns about potential negative impacts from AI on the company.
- He acknowledges underestimating Clover Health Investments but remains focused on long-term prospects of companies like United Health and CVS.
- Cramer is bullish on Vistra despite its recent price decline, recommending a cautious buy with a partial position.
- He is disappointed with Stryker, expecting it to be an industry consolidator, but notes that consolidation has not occurred as anticipated.
